Skip to content

AMGN

AMGEN INC

NASDAQ · Healthcare · Drug Manufacturers - General · US

$469.05
+1.69%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue38.9B36.7B33.4B28.2B26.3B
Cost of Revenue10.1B10.7B12.9B8.4B6.4B
Gross Profit28.8B26.0B20.6B19.8B19.9B
Operating Expenses
R&D Expense7.8B7.0B6.0B4.8B4.4B
SG&A Expense7.0B7.0B7.1B6.2B5.4B
General & Admin Expense——6.1B—4.6B
Selling & Marketing Expense——987.0M—841.0M
Other Expenses155.0M1.3B248.0M879.0M503.0M
Total Operating Expenses15.0B15.3B13.3B11.8B10.4B
Cost and Expenses25.1B26.1B26.2B20.3B16.8B
Operating Income (EBIT)13.8B10.7B7.3B7.9B9.6B
Non-Operating
Interest Income—————
Interest Expense1.3B2.8B3.2B2.9B1.4B
Net Interest Income(2.0B)(2.8B)(3.2B)(2.9B)(1.4B)
Other Non-Op Income/Expense(2.8B)(1.7B)(2.6B)(42.0M)(2.2B)
Non-Operating Income (excl Interest)1.8B(1.1B)(506.0M)(2.8B)814.0M
EBT (Pre-Tax Income)11.1B9.0B4.6B7.9B7.3B
Income Tax Expense1.7B1.3B519.0M1.1B794.0M
Bottom Line
Net Income9.4B7.7B4.1B6.7B6.6B
Earnings from Cont. Ops9.4B7.7B4.1B6.7B6.6B
Earnings from Discont. Ops—————
Bottom Line Net Income9.4B7.7B4.1B6.7B6.6B
Per Share
Basic EPS$17.38$14.33$7.62$12.56$12.18
Diluted EPS$17.24$14.23$7.56$12.49$12.11
Revenue Per Share$71.96$68.29$61.78$52.69$48.93
Shares
Basic Shares Outstanding541.0M538.0M541.0M535.0M538.0M
Diluted Shares Outstanding546.0M542.0M541.0M538.0M541.0M
Profitability Metrics
EBITDA15.4B16.9B13.4B14.8B12.2B
D&A3.4B5.2B5.6B4.1B3.4B
EBIT8.3B11.7B7.8B10.7B8.8B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026